Literature DB >> 16504480

Association between chromogranin A gene polymorphism and schizophrenia in the Japanese population.

Nagahide Takahashi1, Ryoko Ishihara, Shinichi Saito, Nobuhisa Maemo, Nagisa Aoyama, Xiofei Ji, Hideki Miura, Masashi Ikeda, Nakao Iwata, Tatsuyo Suzuki, Tsuyoshi Kitajima, Yoshio Yamanouchi, Yoko Kinoshita, Norio Ozaki, Toshiya Inada.   

Abstract

It has been reported that expression of the chromogranin A (CHGA) gene is reduced in the prefrontal cortex and cerebrospinal fluid of patients with schizophrenia. Single-marker and haplotype analyses of SNPs within the CHGA gene were performed in 633 subjects with schizophrenia and 589 healthy controls. A significant association with schizophrenia was observed to one SNP marker, rs9658635 (p=0.0269), and with a 2 marker haplotype (p=0.0016). Significant association of rs9658635 was then replicated in a second independent cohort (377 schizophrenia and 338 control samples) (p=0.007). These results suggest that the CHGA gene is associated with the risk of developing schizophrenia in the Japanese population.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16504480     DOI: 10.1016/j.schres.2005.12.854

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  9 in total

1.  Hippocampal Pruning as a New Theory of Schizophrenia Etiopathogenesis.

Authors:  Enrico Cocchi; Antonio Drago; Alessandro Serretti
Journal:  Mol Neurobiol       Date:  2015-04-24       Impact factor: 5.590

Review 2.  The extended granin family: structure, function, and biomedical implications.

Authors:  Alessandro Bartolomucci; Roberta Possenti; Sushil K Mahata; Reiner Fischer-Colbrie; Y Peng Loh; Stephen R J Salton
Journal:  Endocr Rev       Date:  2011-08-23       Impact factor: 19.871

3.  Further evidence that the chromogranin B gene confers predisposition to schizophrenia: a family-based association study in Chinese.

Authors:  S Wu; J Ma; Q Xing; Y Xu; J Meng; D Cao; G Feng; L He
Journal:  J Neural Transm (Vienna)       Date:  2006-12-04       Impact factor: 3.575

4.  A genome-wide quantitative linkage scan of niacin skin flush response in families with schizophrenia.

Authors:  Yin-Ju Lien; Sih-Syuan Huang; Chih-Min Liu; Hai-Gwo Hwu; Stephen V Faraone; Ming T Tsuang; Wei J Chen
Journal:  Schizophr Bull       Date:  2011-06-07       Impact factor: 9.306

5.  Decreased cerebrospinal fluid secretogranin II concentrations in severe forms of bipolar disorder.

Authors:  Joel Jakobsson; Mats Stridsberg; Henrik Zetterberg; Kaj Blennow; Carl-Johan Ekman; Anette G M Johansson; Carl Sellgren; Mikael Landén
Journal:  J Psychiatry Neurosci       Date:  2013-07       Impact factor: 6.186

Review 6.  Chromogranin peptides in brain diseases.

Authors:  Michael Willis; Irmgard Leitner; Kurt A Jellinger; Josef Marksteiner
Journal:  J Neural Transm (Vienna)       Date:  2011-04-30       Impact factor: 3.575

7.  Biological function and clinical relevance of chromogranin A and derived peptides.

Authors:  Maria Angela D'amico; Barbara Ghinassi; Pascal Izzicupo; Lamberto Manzoli; A Di Baldassarre
Journal:  Endocr Connect       Date:  2014-04-29       Impact factor: 3.335

8.  The regulated secretory pathway and human disease: insights from gene variants and single nucleotide polymorphisms.

Authors:  Wei-Jye Lin; Stephen R Salton
Journal:  Front Endocrinol (Lausanne)       Date:  2013-08-06       Impact factor: 5.555

9.  Associations between SNPs and immune-related circulating proteins in schizophrenia.

Authors:  Man K Chan; Jason D Cooper; Stefanie Heilmann-Heimbach; Josef Frank; Stephanie H Witt; Markus M Nöthen; Johann Steiner; Marcella Rietschel; Sabine Bahn
Journal:  Sci Rep       Date:  2017-10-03       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.